Edap Tms (FOCL) Net Cash Flow Growth (3y) (2012 - 2026)
Edap Tms (FOCL) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -18.44% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 57.86% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 51.09% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -86.09% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 44.39% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 165.77% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 3.36% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | -55.20% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 45.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.36% |
| Dec 31, 2025 | -6.22% |
| Sep 30, 2025 | -54.60% |
| Jun 30, 2025 | -56.10% |
| Mar 31, 2025 | -262.39% |
| Dec 31, 2024 | 56.49% |
| Sep 30, 2024 | -183.52% |
| Jun 30, 2024 | -33.17% |
| Mar 31, 2024 | -90.47% |
| Sep 30, 2023 | -41.95% |
| Jun 30, 2023 | -0.58% |
| Dec 31, 2012 | 62.38% |